DrugInserts.com: Trustworthy FDA Drug Information

Over the Counter Medications

Package Insert and Label Information: SUDATEX – DM

By Larken Laboratories Inc. | Last revised: 18 April 2012

SUDATEX — DM — dextromethorphan hydrobromide, guaifenesin and pseudoephedrine hydrochloride tablet
Larken Laboratories Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active Ingredients (per tablet)

Dextromethorphan HBr 20 mg
Guaifenesin 400 mg
Pseudoephedrine HCl 40 mg

Purpose

Dextromethorphan HBr Antitussive
Guaifenesin Expectorant
Pseudoephedrine HCl Decongestant

Uses

temporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergies

helps loosen phlegm (mucus)
nasal congestion
thin bronchial secretions
drain bronchial tubes
make coughs more productive
stuffy nose
clear nasal passageways
shrinks swollen membranes

Warnings

Do not use more than the recommended dosage

Do not use

this product if you are now taking a prescription Monoamine Oxidase Inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you are uncertain whether your prescription drug contains an MAOI, ask a health professional.

Ask a doctor before use if you have

heart disease
excessive phlegm (mucus)
high blood pressure
diabetes
thyroid disease
difficulty in urination due to enlargement of the prostate gland
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema

Stop use and ask a doctor if

nervousness, dizziness, or sleeplessness occurs
symptoms are accompanied by fever, rash, persistent headache, or excessive phlegm (mucus)
cough and congestion do not improve within 7 days or tend to recur
These could be signs of a serious condition.

If pregnant or breast-feeding

ask a health professional before use.

Keep out of the reach of children

In case of accidental overdose, get medical help or contact a Poison Control immediately.

Directions

Adults and Children over 12 years of age: 1 tablet every 4-6 hours, not to exceed 6 tablets in a 24 hour period.
Children 6 to under 12 years of age: take 1/2 tablet every 4-6 hours, not to exceed 3 tablets in a 24 hour period.
Children under 6 years of age: ask a doctor.

Other Information

store at 15°-30°C (59°-86°F)
do not use if imprinted safety seal under cap is broken or missing

Inactive Ingredients

Croscarmellose Sodium, Magnesium Stearate, Maltodextrin, Microcrystalline Cellulose, Polyvinylpyrrolidone, Silica and Stearic Acid.

Questions or Comments?

Call 1-888-527-5522 weekdays from 9:00 am to 4:00 pm CST or go to http://www.larkenlabs.com.

Distributed by:
Larken Laboratories, Inc.
Canton, MS 39046

Principal Display Panel

Figure 1: Container Label

3a8a1ffd-figure-01
(click image for full-size original)
SUDATEX — DM
dextromethorphan hbr, guaifenesin, and pseudoephedrine hcl tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:68047-247
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN) DEXTROMETHORPHAN HYDROBROMIDE 20 mg
GUAIFENESIN (GUAIFENESIN) GUAIFENESIN 400 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE) PSEUDOEPHEDRINE HYDROCHLORIDE 40 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
MALTODEXTRIN
CELLULOSE, MICROCRYSTALLINE
CROSPOVIDONE
SILICON DIOXIDE
STEARIC ACID
Product Characteristics
Color WHITE Score no score
Shape OVAL Size 17mm
Flavor Imprint Code LL242
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68047-247-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part341 09/22/2011 01/31/2013
Labeler — Larken Laboratories Inc. (791043719)
Establishment
Name Address ID/FEI Operations
Contract Pharmacal Corp. 968334974 MANUFACTURE

Revised: 04/2012 Larken Laboratories Inc.